Wuxi Biortus Biosciences

Compound screening against a drug target is a vital step in early stage drug discovery. Biortus has an extensive collection of testing equipment that allows development of many kinds of biochemical assays, biophysical assays, and cell-based assays. Key assays include SPR, Kinase, ADP-Glo, TR-FRET, FP, Cali...

Our experienced teams have supplied many different drug-target proteins for our clients, including membrane proteins such as GPCR, ion channel, transporters etc. Others include kinases, virus proteins, E3 ligases, CDKs, and many more. Our standard expression systems include E.coli, insect cells, and mammal...

Attaining atomic resolution biomolecular structures using cryo-EM is now a ubiquitous reality. Biortus sees great potential in cryo-EM for its use in structure-based drug discovery. From large protein/protein complexes, membrane proteins, proteins with dynamic conformation to viral structures and epitope m...

A general introduction of Biortus the company and its technology platforms: Protein Production, Assay Development and Compound Screening, Structural Biology (crystallography, cryoEM, microED).